Search for: "Pfizer Pharmaceutic, Inc."
Results 421 - 440
of 667
Sort by Relevance
|
Sort by Date
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
5 Apr 2010, 7:23 pm
Pfizer Defends Epilepsy Drug Neurontin at Fraud Trial (Update3), BusinessWeek, March 23, 2010 Pfizer faces $142 million in damages for drug fraud, KBOI2.com/AP, March 26, 2010 Related Web Resources: Pfizer Neurontin [read post]
31 Mar 2010, 1:58 pm
" Pfizer, Inc. v. [read post]
30 Mar 2010, 3:53 am
Pfizer, Inc., that giant of the pharmaceutical industry, was found by a jury in U.S. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
26 Feb 2010, 4:17 pm
Pfizer, Inc. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]
17 Feb 2010, 8:00 am
(patent infringement) 2/3: Pfizer Inc., Pfizer Pharmaceuticals LLC, Pfizer Ireland Pharmaceuticals, Pfizer Limited and CP Pharmaceuticals International CV v. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
15 Feb 2010, 12:36 pm
In Ex parte PFIZER, INC (Appeal 2009-004106 ), the BPAI contemplated the validity of Pfizer's patent claim:A method of treating erectile dysfunction in a male human, comprising orally administering to a male human in need of such treatment an effective amount of a selective cGMP PDEV inhibitor, or a pharmaceutically acceptable salt thereof, of [sic, or] a pharmaceutical composition containing either entityThe Examiner had rejected the claim under… [read post]
15 Feb 2010, 12:00 pm
See Pfizer Inc., et al. v. [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
26 Jan 2010, 9:59 pm
Hoffman-La Roche Ltd., Pfizer, Inc. v. [read post]
